We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$404M
AUM Growth
+$32.8M
Cap. Flow
-$1.92M
Cap. Flow %
-0.48%
Top 10 Hldgs %
33.2%
Holding
179
New
8
Increased
48
Reduced
50
Closed
1

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$708K
2
GILD icon
Gilead Sciences
GILD
+$398K
3
PGR icon
Progressive
PGR
+$355K
4
ADP icon
Automatic Data Processing
ADP
+$343K
5
VZ icon
Verizon
VZ
+$236K

Sector Composition

Rank Sector Weight
1 Technology 19.38%
2 Financials 15.13%
3 Healthcare 15.02%
4 Consumer Discretionary 11.72%
5 Industrials 10.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$5.05M 1.25%
19,282
+355
+2% +$95.2K
WY icon
27
Weyerhaeuser
WY
$18B
$5M 1.24%
162,047
-180
-0.1% -$5.58K
TROW icon
28
T. Rowe Price
TROW
$23.9B
$4.93M 1.22%
45,167
-270
-0.6% -$30.5K
SYY icon
29
Sysco
SYY
$40.8B
$4.89M 1.21%
64,308
-202
-0.3% -$16.3K
ZBRA icon
30
Zebra Technologies
ZBRA
$14B
$4.81M 1.19%
18,498
+650
+4% +$168K
WERN icon
31
Werner Enterprises
WERN
$2.24B
$4.71M 1.17%
115,731
+1
+0% +$41
TECH icon
32
Bio-Techne
TECH
$11.2B
$4.16M 1.03%
50,420
-1,860
-4% -$148K
CPRT icon
33
Copart
CPRT
$27B
$4.07M 1.01%
132,522
-3,210
-2% -$96.1K
SON icon
34
Sonoco
SON
$5.57B
$3.93M 0.97%
65,168
PAYX icon
35
Paychex
PAYX
$41.6B
$3.78M 0.94%
32,630
+20
+0.1% +$2.34K
PFE icon
36
Pfizer
PFE
$143B
$3.77M 0.93%
73,592
-368
-0.5% -$17.6K
GILD icon
37
Gilead Sciences
GILD
$162B
$3.58M 0.89%
41,885
-5,025
-11% -$398K
CSX icon
38
CSX Corp
CSX
$93.4B
$3.54M 0.88%
114,646
+19
+0% +$571
KMB icon
39
Kimberly-Clark
KMB
$36.3B
$3.43M 0.85%
24,990
-210
-0.8% -$26.7K
JPM icon
40
JPMorgan Chase
JPM
$935B
$2.98M 0.74%
22,086
DUK icon
41
Duke Energy
DUK
$97.8B
$2.87M 0.71%
27,654
+15
+0.1% +$1.44K
MMS icon
42
Maximus
MMS
$3.17B
$2.78M 0.69%
37,660
+1,126
+3% +$72.7K
CTAS icon
43
Cintas
CTAS
$81.9B
$2.78M 0.69%
24,744
-56
-0.2% -$6.06K
COST icon
44
Costco
COST
$422B
$2.77M 0.69%
6,105
+60
+1% +$29.3K
EMR icon
45
Emerson Electric
EMR
$83.9B
$2.75M 0.68%
28,649
+2
+0% +$180
PDCO
46
DELISTED
Patterson Companies, Inc.
PDCO
$2.66M 0.66%
95,332
+3,010
+3% +$83.1K
WM icon
47
Waste Management
WM
$90.6B
$2.33M 0.58%
14,858
+700
+5% +$113K
AFL icon
48
Aflac
AFL
$64.9B
$2.3M 0.57%
32,201
-371
-1% -$24.8K
TFX icon
49
Teleflex
TFX
$6.05B
$2.21M 0.55%
8,838
SBUX icon
50
Starbucks
SBUX
$120B
$2.18M 0.54%
21,668
-1,550
-7% -$146K

Similar funds

Rowlandmiller & Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Rowlandmiller & Partners held 179 positions worth $404M, up 8.8% from $371M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Rowlandmiller & Partners's Q4 2022 filing shows 8 new, 48 increased, 50 reduced and 1 closed positions. Its largest new stake was Simon Property Group: 1,000 shares worth $118K. The largest sale was Eli Lilly, an estimated $708K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Rowlandmiller & Partners's largest Q4 2022 buy was Simon Property Group: 1,000 shares worth $118K.
  • Rowlandmiller & Partners added most to Zebra Technologies in Q4 2022, an estimated $168K increase.
  • Rowlandmiller & Partners's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $708K.
  • Rowlandmiller & Partners fully exited Citigroup in Q4 2022, selling an estimated $185K.
  • Rowlandmiller & Partners's ten largest holdings make up 33% of its $404M portfolio in Q4 2022.
  • Rowlandmiller & Partners opened 8 new positions and closed 1 in Q4 2022.
  • Rowlandmiller & Partners's portfolio value rose 8.8% quarter-over-quarter to $404M.

Based on Rowlandmiller & Partners's 13F filing for Q4 2022, filed 4 Jan 2023.